InsiderTrades.com logo
Brent M. Longnecker net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Brent Longnecker Biography and Net Worth

Director of Genprex

Brent Longnecker has more than 30 years of experience in corporate governance, executive compensation, and risk management consulting for public, private, and non-profit organizations. Mr. Longnecker built one of the country’s leading privately-held executive compensation and corporate governance consultancies, serving both domestic and international markets. Mr. Longnecker has deep expertise in healthcare, energy, real estate, manufacturing, and financial companies, regularly consulting with boards of directors, CEOs, key executives, and advisors  in many major industries. He is a prolific author on the subjects of executive compensation and corporate governance.

What is Brent M. Longnecker's net worth?

The estimated net worth of Brent M. Longnecker is at least $1.12 thousand as of April 14th, 2026. Longnecker owns 416 shares of Genprex stock worth more than $1,117 as of October 9th. This net worth approximation does not reflect any other investments that Longnecker may own. Learn More about Brent M. Longnecker's net worth.

How do I contact Brent M. Longnecker?

The corporate mailing address for Longnecker and other Genprex executives is 3300 Bee Cave Road Suite 650-227, Austin, TX, 78746. Genprex can also be reached via phone at (877) 774-4679 and via email at [email protected]. Learn More on Brent M. Longnecker's contact information.

Has Brent M. Longnecker been buying or selling shares of Genprex?

Brent M. Longnecker has not been actively trading shares of Genprex during the last ninety days. Most recently, Brent M. Longnecker sold 0 shares of the business's stock in a transaction on Tuesday, April 14th. The shares were sold at an average price of $27.06, for a transaction totalling $0.00. Following the completion of the sale, the director now directly owns 416 shares of the company's stock, valued at $11,256.96. Learn More on Brent M. Longnecker's trading history.

Are insiders buying or selling shares of Genprex?

During the last year, insiders at the sold shares 2 times. They sold a total of 0 shares worth more than $0.00. The most recent insider tranaction occured on April, 14th when Director Brent M Longnecker sold 0 shares worth more than $0.00. Insiders at Genprex own 0.3% of the company. Learn More about insider trades at Genprex.

Information on this page was last updated on 4/14/2026.

Brent M. Longnecker Insider Trading History at Genprex

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/14/2026Sell0$27.06$0.00416View SEC Filing Icon  
4/14/2026Sell0$27.06$0.00416View SEC Filing Icon  
See Full Table

Brent M. Longnecker Buying and Selling Activity at Genprex

This chart shows Brent M. Longnecker's buying and selling at Genprex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Genprex Company Overview

Genprex logo
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company's lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes. Its product pipeline comprises Acclaim-1, which is in phase 2a clinical trial for the treatment of non-small cell lung cancer; Acclaim-2, which is in phase phase 1/2 clinical trial for the treatment of non-small cell lung cancer; and Acclaim-3, which is in phase 1/2 clinical trial for the treatment of small cell lung cancer. The company also develops ONC-001, REQORSA as a monotherapy, which is in phase 1 clinical trial to treat advance non-small cell lung cancer; and ONC-002, REQORSA with Tarceva, which is in phase 2 clinical trial to treat non-small cell lung cancer. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Read More

Today's Range

Now: $2.71
Low: $2.64
High: $2.93

50 Day Range

MA: $3.69
Low: $2.56
High: $5.99

2 Week Range

Now: $2.71
Low: $2.53
High: $1,210.00

Volume

170,949 shs

Average Volume

107,356 shs

Market Capitalization

$2.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A